Assessment of Mass Drug Administration its gaps and challenges in Tikamgarh District of Madhya Pradesh

Authors

  • Madhav Bansal
  • Nainshree Singh
  • Mugdha Kamble

Keywords:

Mass Drug Administration, Filariasis, Elephantiasis, DEC, Albendazole, Lymphatic Filariasis

Abstract

Introduction: Lymphatic Filariasis is endemic in India, thus annual mass drug administration (MDA) with
diethylcarbamazine (DEC) and albendazole is done. Continued administration for 4-6 years with >65%
coverage will interrupt the transmission of filariasis. This study aims to find out the reasons of noncompliance
and the operational issues in MDA. Objectives: [1] To review the coverage and compliance of DEC +
albendazole [2] To assess the implementation of MDA and find out the gaps and challenges. Methodology:

Four clusters, one urban and 3 from rural, were selected by multistage random sampling. From 4 blocks
selected, 1 urban ward and 3 PHC were selected, 1 village from each PHC was surveyed for 30 households.
Results: 785 people were surveyed in 120 households from 4 blocks, 96.2% (754) were eligible population.
75% (567) were above 15 years, 19% (141) were 5-14 years of age and 6% (46) were 2-4 years of age. 91.4%
(689) people received tablets during the MDA, 74.5% (513) ingested the tablets. 33.1% (228) ingested in the
presence of drug sewak and 70.7% (487) after food. Conclusion: Coverage of consumption far below the
reported coverage of the district. Lack of awareness and poor counselling and IEC were found to be major
reasons for lack of compliance.

Downloads

Published

2024-01-24

How to Cite

Bansal, M., Singh, N., & Kamble, M. (2024). Assessment of Mass Drug Administration its gaps and challenges in Tikamgarh District of Madhya Pradesh . Indian Journal of Preventive & Social Medicine, 54(4), 166–174. Retrieved from https://ijpsm.co.in/index.php/ijpsm/article/view/87